Role of Ca2+ in structure and function of Complex I from Escherichia coli  by Verkhovskaya, Marina et al.
Biochimica et Biophysica Acta 1807 (2011) 36–41
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbab ioRole of Ca2+ in structure and function of Complex I from Escherichia coli
Marina Verkhovskaya ⁎, Juho Knuuti, Mårten Wikström
Helsinki Bioenergetics Group, Institute of Biotechnology, PO Box 65 (Viikinkaari 1) FIN-00014 University of Helsinki, FinlandAbbreviations: DDM, n-dodecyl β-D-maltopyranoside
(III) chloride; DQ, decylubiquinone; FeCy, ferricyanid
1,3-bis(tris(hydroxymethyl)methylamino)propane; N
⁎ Corresponding author. Tel.: +358 9 191 59749; fax
E-mail address: Marina.Verkhovskaya@Helsinki.Fi (M
0005-2728/$ – see front matter © 2010 Elsevier B.V. A
doi:10.1016/j.bbabio.2010.09.002a b s t r a c ta r t i c l e i n f oArticle history:
Received 2 June 2010
Received in revised form 1 September 2010
Accepted 8 September 2010
Available online 15 September 2010
Keywords:
Complex I
Cation binding site
Ca2+-binding siteThedependenceofE. coliComplex I activity on cation chelators suchasEDTA, EGTA,NTAando-phenanthrolinewas
studied in bacterial membranes, puriﬁed solubilized enzyme and Complex I reconstituted into liposomes. Puriﬁed
Complex I was strongly inhibited by EDTA with an I50 of approximately 2.5 μM. The effect of Mg2+ and Ca2+ on
EGTA inhibition of puriﬁed Complex I activity indicated that Ca2+ is tightly bound to the enzyme and essential for
the activity. Low sensitivity to o-phenanthroline argues against the occupation of this cation binding site by Fe2+ or
Zn2+. The sensitivity of Complex I to EDTA/EGTA strongly depends on the presence of monovalent cations in the
medium, and on whether the complex is native, membrane-bound, or puriﬁed. The data is discussed in terms of a
possible loss either of an additional 14th, subunit of E. coli Complex I, analogous to Nqo15 in the T. thermophilus
enzyme, or another component of the native membrane that affects the afﬁnity and/or accessibility of the Ca2+
binding site.; HAR, hexaammineruthenium
e; DEA, diethanolamine; BTP,
TA, nitrilotriacetic acid
: +358 9 191 58003.
. Verkhovskaya).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
NADH:ubiquinone oxidoreductase type 1 (Complex I) constitutes
the beginning of the respiratory chain in mitochondria and many
bacteria. Even the “minimal” bacterial version consists of 6 hydro-
philic and 7 hydrophobic subunits, and due to this complexity the
knowledge of its structure and molecular mechanism is limited.
Recently, several metal binding sites were revealed in the hydrophilic
domain of T. thermophilus Complex I by analysis of its X-ray
structure [1]. One of these sites is located between subunits Nqo15
and Nqo3, and is occupied by a tightly bound metal ion tentatively
assigned as Ca2+, which was suggested to stabilize the Nqo15–Nqo3
interaction. The other site(s) situated in an acidic groove of Nqo3
could also contain tightly bound Ca2+. One further metal binding site
formed by amino acid residues of the Nqo2 and Nqo1 subunits is
located in the vicinity of the interface between Nqo15 and the rest of
Complex I, which was considered as a putative iron-binding channel
[2]; the metal bound there was identiﬁed as Mn2+. However, it was
suggested that this site may be occupied by Fe2+ in native conditions
and that it may serve as an iron reservoir in case of damage to the
neighbor FeS cluster, N1a [1]. The role of bound divalent cations in
Complex I still remains unclear: the putative binding sites determined
from the T. thermophilus Complex I structure are located between theother subunits and Nqo15, but so far this frataxin-like subunit was
identiﬁed only in the T. thermophilus enzyme structure. The genes for
homologous proteins were found only in the genomes of other
thermophilic bacteria, which are close relatives of T. thermophilus [3],
but not in E. coli. The question therefore arises whether these metal
binding sites are constitutive for Complex I from different sources, or
whether they are unique features of Complex I from thermophiles.
Recently, one zinc ion per molecule of mitochondrial Complex I was
foundby ICP emission spectrometry [4] andEXAFS [5]. Thephysiological
role of Zn2+ in Complex I is unknown but it was suggested to be tightly
bound because it was not released by EDTA treatment [4]. Since bound
Zn2+ was not detected in the resolved structure of T. thermophilus
Complex I it may be unique for the mitochondrial enzyme, or could be
located in the membrane subunits that were not present in the crystal
structure.
It is not known yet whether the bound divalent cations are
intrinsic for the entire Complex I family and essential for structure/
function. So far not much information about the interaction of these
cations with Complex I is available, although they were shown to
cause multiple effects on mitochondrial and bacterial Complex I. In
the mitochondrial enzyme Ca2+ was found to attenuate GTP binding
[6], and Mg2+ and Ca2+ prevented the Complex I transition from an
inactive to the active state [7,8]. Bacterial Complex I is stabilized by
Ca2+ [9], but its ubiquinone reductase activity is moderately inhibited
by Mg2+ and Ca2+ in the millimolar concentration range [10].
We performed titrations of various E. coli Complex I activities in
different states of the enzyme, and with a number of ion chelators. The
results show that at least one tightly boundmetal, most probably Ca2+,
is required tomaintain the activity. The accessibility of this site towater-
soluble chelators such as EDTA and EGTA, and/or the afﬁnity to Ca2+,
depends on whether Complex I is solubilized or membrane-bound.
Fig. 1. Initial activity of Complex I in different states. A. NADH consumption upon NADH:
ubiquinone oxidoreduction by Complex I in different preparations; NADH was added at
zero time; B. derivatives of NADH consumption curves representing the rates of Complex I
ubiquinone reductase activity. The curves were normalized by their maximal values: 1.6
and 1.7, large and small scalemembrane preparations respectively, 26, puriﬁed solubilized
Complex I, 35, puriﬁed reconstituted Complex I, μmol mg−1 min−1. Membrane-bound
Complex I, large scale membrane preparation, dotted line; small scale membrane
preparation, dashed line; puriﬁed solubilized Complex I, solid line; puriﬁed reconstituted
Complex I, dash–dot line.
37M. Verkhovskaya et al. / Biochimica et Biophysica Acta 1807 (2011) 36–412. Materials and methods
2.1. Bacterial growth and puriﬁcation of Complex I
The E. coli MWC215 (SmR ndh::CmR) strain was grown in an LB
medium at 37 °C in a 25 L fermentor and harvested at the late
exponential growth phase. The membranes for Complex I puriﬁcation
(large batch) were prepared by passing the cells through an APV
Gaulin homogenizer as described in [11]. Complex I was puriﬁed in
two chromatography steps, using anion exchanger DEAE-Trisacryl M
(Bio-Sepra) columns and gel ﬁltration on Superdex 200 prep grade
(GE Healthcare) [10].
2.2. Measurements of catalytic activity
HAR and DQ reductase activities of puriﬁed or membrane-bound
Complex I were measured by following NADH oxidation at 340 nm
(ε=6.2 mM−1 cm−1) [11] in the basic buffer containing 25 mM
HEPES-BTP, pH 7.5, if not indicated otherwise. Concentrations of
substrates added were 100 μM for DQ, 360 μM for HAR and 200 μM for
NADH. For the measurements of the ubiquinone reductase activity of
puriﬁed solubilized Complex I, the basic buffer was supplemented
with 0.005% DDM and 20 nM ubiquinol oxidase bo3. For the
measurements of the activity of reconstituted Complex I, the basic
buffer was supplemented with 10 μg/ml alamethicin and 20 nM
ubiquinol oxidase bo3. DQ reductase activity of puriﬁed Complex I was
fully sensitive to rolliniastatin [12].
2.3. Analytical procedures
Protein concentrations inmembranes were determined by the BCA
protein assay reagent kit and for a puriﬁed protein Pierce 660 nm
protein assay reagent was used (both from Thermo Scientiﬁc) Bovine
serum albumin was used as a standard in both cases.
2.4. Membrane-bound Complex I preparations
A small batch of membranes was prepared from freshly grown
cells by a fast protocol employingmild sonication of lysozyme treated,
osmotically sensitive cells as described in [13]. Large batch mem-
branes were obtained as described in [11] from the cells grown in
fermentor, frozen and then disrupted by means of the APV Gaulin
homogenizer. The small batch membranes are expected to be in a
more native state than the membranes prepared from the cells grown
in a fermentor where a fast preparation procedure and mild
conditions are impossible.
2.5. Reconstitution of Complex I into liposomes and monitoring of ΔpH
and Δψ generation upon NADH:DQ oxidoreduction
Asolectin at concentration 6 mg/ml was suspended in 200 mM
MES-KOH buffer, pH 6.75, containing 0.5% DDM by sonication
until clear, then puriﬁed Complex I was added to a concentration of
0.2–0.3 mg/ml. 1 mM of pyranine was added when the proteolipo-
somes were used for ΔpH monitoring. The mixture was allowed to
equilibrate for 30 min at room temperature; then 400 mg/ml SM-2
BioBeads (Bio-Rad Laboratories), were added to remove the deter-
gent. After 2 h at RT under gentle agitation the BioBeads were
removed, the prepared proteoliposomes were diluted with 200 mM
MES-KOH, pH 6.75, and pelleted by centrifugation at 170000 g for
90 min. The pellet was carefully washed and the proteoliposomes
were suspended in a small volume of the same buffer. The orientation
of reconstituted Complex I was tested by measurements of NADH:
HAR oxidoreductase activity in the presence and absence of
alamethicin. It was found that approximately 70% of Complex I was
incorporated into the liposomes with the hydrophilic fragmentoutwards. The proteoliposomes were used for monitoring the Δψ by
means of the electric potential-sensitive dye, Oxonol VI. Changes in
absorption at 625–580 nm were measured with a Shimadzu dual-
wavelength/double-beam UV3000 Spectrophotometer. The assay
contained 200 mM MES-KOH, pH 6.75, and 0.5 mM MgSO4, 100 nM
monensin, 0.5 μM Oxonol VI, proteoliposomes (6–8 μg Complex I/ml)
and 60 μM DQ. The reaction was started by 100 μM NADH addition.
ΔpH generationwasmonitored by following the ﬂuorescence changes
of the water-soluble pH-indicator pyranine (λem=510 nm,
λex=460 nm) entrapped in the proteoliposomes in the same buffer,
but instead of monensin the medium was supplemented with 0.5 μM
valinomycin.3. Results
3.1. Non-linear DQ reductase activity
The curves of NADH consumption by DQ reduction were not linear
for all tested Complex I preparations (Fig. 1A), which is much more
evident when the derivatives of these curves, are depicted (Fig. 1B).
The activity of the enzyme in the membrane preparations has
no (small scale) or negligible (large scale) lag phase but after
Fig. 2. Titration of Complex I NADH:HAR (squares) and NADH:DQ oxidoreductase
(circles) activities by EDTA. A, Membrane-bound Complex I, small batch membranes
speciﬁcally obtained for proton-pumping measurements, gray symbols, and large batch
membranes obtained from cells grown in the fermentor, open symbols. B, Puriﬁed,
solubilized Complex I. C, Puriﬁed Complex I reconstituted into the liposomes.
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solubilized Complex I was activated upon turnover, the rate of NADH
oxidation was increased 2–3 times during 40 s, approached the
maximal value and then decreased after 60 s (Fig. 1B). After
reconstitution the lag phase was shorter, and the activation was
40–20% depending on the preparation However, the activation time
was close to that for solubilized Complex I or longer; then the
activity was also decreased. The observed lag phase is not very
unusual: some membrane enzymes (e.g. succinate dehydrogenase
[14] and cyt c oxidase [15]) are known to convert to an inactive state
upon preparation and require turnovers for full activation. The
decrease of the activity was most probably due to a slow exchange of
the reduced ubiquinone between lipid membranes or detergent/
protein micelles and the bulk solution and, therefore, ubiquinol
accumulation in the enzyme milieu. To compare the activity of
solubilized and reconstituted Complex I at different conditions the
values of the activity in the interval 45–60 s (Fig. 1B) were averaged
and plotted against the chelator concentration.
3.2. Effect of EDTA on the HAR and DQ reductase activity of
membrane-bound, solubilized and reconstituted Complex I
We found that Complex I bound to native membranes is not very
sensitive to EDTA. Artiﬁcial HAR reductase and natural DQ reductase
activities were both decreased less than 10% by EDTA for small batch
membranes (the membranes prepared for the best measurements of
proton-pumping activity [13]), and by about 30% for large batch
membranes obtained for Complex I puriﬁcation from the cells grown
in the fermentor (Fig. 2A). The drop of activity happened already upon
addition of 5 μM EDTA; after that the activity stayed unchanged up to
an EDTA concentration of 1–2 mM (not shown). The solubilized
Complex I is much more sensitive to EDTA. Both activities drop by
75–80% (Fig. 2B). The half-effect was approached at the same
concentration of EDTA of approximately 2.5 μM, as for the membranes.
The effect of EDTA on reconstituted Complex I was intermediate,
50–60% activity was lost (Fig. 2C). However, when the liposomes were
washed once they became as sensitive to EDTA as the solubilized
enzyme.
The drop of the HAR and DQ reductase activities upon addition of
chelators goes in parallel, but the artiﬁcial activity is 3–4 times higher
than the natural one. This suggests that the EDTA treatment does not
result in some gradual changes in the electron transfer but rather
blocks almost completely the activity of a certain fraction of the
enzyme. In line with this is the observation that even FeCy reductase
activity of puriﬁed Complex I is depressed by EDTA, although to a
lower extent, only 30–50% was lost (Supplementary Fig. 1S). Since
there are strong indications that FeCy accepts electrons directly from
FMN [16] the architecture of the input catalytic site of Complex I must
be disturbed by the EDTA treatment. Although the reconstituted
Complex I is highly sensitive to EDTA, almost as sensitive as the
solubilized enzyme but differently from native membrane-bound
Complex I, it is nevertheless competent in the translocation of H+
across the membrane as veriﬁed by measurements of Δψ and ΔpH
(Fig. 3).
3.3. Effect of NTA and o-phenanthroline on Complex I activity
To ﬁnd out whatmetal is removed by EDTA, Complex I activity was
titrated with other chelators. EDTA and EGTA, which are very similar
in structure and binding properties, showed the same effect on
Complex I activity although the afﬁnity of EGTA for Ca2+ is higher. It
could therefore be expected that EGTA should inhibit the enzyme at
lower concentrations than EDTA. However, at such low concentration
of the chelator (micromolar scale) kinetic factors become limiting.
Within the time range of the reaction (Fig. 1) the divalent cation
depletion of the enzyme by the chelators does not reach equilibrium.This is the limitation of the used approach which is why a proper
determination of the I50 for EGTA was not possible. The preincubation
with the chelators would release this time limitation, however the
activity is measured at pH 7.5, but Complex I is highly unstable at pH
higher than 6.0, which makes the preincubation unfeasible. NTA is
efﬁcient at a concentration more than 2 orders of magnitude higher
(Fig. 4). Since NTA binds Mg2+ and Ni2+ with the same afﬁnity as
EGTA, but has much lower afﬁnity for Zn2+ and Ca2+, it appears that
the metal bound to Complex I is one of the latter.
o-Phenanthroline is a strong chelator of Zn2+ and Fe2+ and is used
for depleting the enzymes of Zn2+. o-Phenanthroline was shown to
be a weak inhibitor of only the quinone reductase activity of
mitochondrial and P. denitriﬁcans Complex I [17]. We observed the
same effect on solubilized and membrane-bound Complex I from
E. coli. o-Phenanthroline inhibited DQ reductase activity with a half-
effect at 100 μMwithout any inﬂuence on HAR activity (not shown).
Therefore, o-phenanthroline has most probably another target than
Fig. 3.MonitoringΔpH andΔψ generation by Complex I reconstituted into liposomes. A.
Generation of ΔpH, acidic inside, followed by ﬂuorescence changes of pyranine
entrapped in the proteoliposomes; ΔpH was dissipated by following additions of
monensin 100 nM and 1 μM. B. Generation of Δψ, positive inside, was followed by
means of Oxonol VI; Δψ was dissipated by the addition of 1 μg/ml gramicidin.
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reported for a bacterial reaction center [18]. From this data we can
conclude that the cation removed by EDTA is most likely Ca2+.Fig. 4. Titration of NADH:DQ oxidoreductase activity of puriﬁed, solubilized Complex I
with EGTA (circles) and NTA (squares).3.4. Identiﬁcation Ca2+ as a tightly bound divalent cation in Complex I
Although the effect of the chelators is irreversible, at least in the
time scale of the experiments, it can be prevented. The prevention of
inhibition of Complex I activity by EDTA or EGTA by addition of
equivalent amounts of Mg2+ and Ca2+ (Fig. 5) also indicates that it is
likely the Ca2+ that is tightly bound. The afﬁnity of EGTA for Mg2+ is
much lower than that of EDTA, which allows us to discriminate
between bound Ca2+ and Mg2+ in the protein. In the presence of an
equimolar amount of Mg2+ Complex I activity was only partially
inhibited by 20 μMEDTA, and in the presence of an equimolar amount
of Ca2+ the activity approached the control level without chelators.
Upon inhibition by 20 μM EGTA the presence of 20 μMMg2+ prevents
the inhibitionmuch less (Fig. 5), and the presence of 20 μMCa2+ again
returns the activity to the control level. The phenomenon was less
prominent with quinone reductase activity (Fig. 5A), but clearly
evident with HAR and FeCy reductase activities (Fig. 5B and
Supplementary Fig. 2S), where there was practically no difference in
EGTA inhibition whether Mg2+ was added to the test buffer or not.
This data also makes it unlikely that a transition metal is responsible
for this phenomenon. Transition metals have a much higher afﬁnity
for EDTA and EGTA; therefore Ca2+ should not completely restore the
activity.
3.5. K+ ions confer Complex I insensitivity to EDTA
It was found that the Complex I activity becomes chelator
insensitive in the presence of K+ (Fig. 6). Surprisingly, this effectFig. 5. Prevention of the chelators' inhibitory effect by Mg2+ and Ca2+. The ubiquinone
reductase (A) and HAR reductase (B) activities of solubilized Complex I inhibited by
20 μM EDTA or EGTA in the presence and absence of MgCl2 and CaCl2 at equimolar
concentration as indicated. 100% activity corresponds to 110–150 for HAR reductase
and 25–35 for DQ reductase μmol NADH mg−1 min−1.
Fig. 6. Titration of DQ reductase activity of puriﬁed, solubilized Complex I in the
presence of different monovalent cations by EDTA. The medium contained 100 mM of
KOH (squares), NaOH (circles) or DEAOH (triangles) adjusted by HEPES to pH 7.5.
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(not shown) resulted only in a partial effect whereas the organic
cations DEA+ and BTP+ were practically inefﬁcient. It is noteworthy
that the stability of Complex I correlates with its sensitivity to EDTA;
stability is much higher for a native membrane-bound enzyme than
for solubilized Complex I, and K+ ions speciﬁcally stabilize Complex I
in all preparations (not shown).4. Discussion
The reported data indicates that the inhibitory effect of the
chelators on E. coli Complex I activity may best be explained by the
removal of tightly bound Ca2+. The possibility that the chelator anions
may be inhibitory themselves cannot be completely excluded, but the
action of NTA (Fig. 4), a chemically very different chelator, where
inhibition is proportional to its afﬁnity to Ca2+, argues against this
suggestion. The other ﬁnding that contradicts the effect of free EGTA is
that inhibition of HAR reductase activity by 20 μM EGTA is practically
unaltered regardless of the presence of 20 μM Mg2+ (Fig. 4B); after
addition of the Mg2+ the concentration of free EGTA is negligible.
These ﬁndings, together with the known Ca2+ binding site in the
structure of the hydrophilic part of Complex I from T. thermophilus [1],
make it very unlikely that the chelators would be inhibitory
themselves.
Comparison to the cation binding sites found in the T. thermophilus
Complex I structure is not straightforward. In the T. thermophilus
Complex I structure tightly bound Ca2+ is located at the interface
between two subunits, Nqo3 and Nqo15, which participate equally in
the formation of thebinding site. The former corresponds toNuoG in the
E. coli enzyme, but the latter is absent. Another cation binding site in the
T. thermophilusComplex I,which is located in a proposed “iron channel”,
and contains a cation identiﬁed as Mn2+, is formed by amino acid
residues from subunits Nqo1 and Nqo2 [1], but only one out of four
metal ligands, S77 in NuoE (counterpart of S68 in Nqo2), is present in
the E. coli enzyme. The other three ligands in the T. thermophilus enzyme
do not have clear counterparts in E. coli and the region of their location
based in the alignment is not conserved in the NuoE subunit. However,
the cation binding site in NuoE may be formed by the side chains of
different amino acid residues or even by the backbone, but in this case it
wouldbedifﬁcult atﬁrst glance to explainhowthe site situatedbetweensubunits NuoF and NuoE, which are at a signiﬁcant distance from the
membrane, may be disturbed by Complex I solubilization and
puriﬁcation. A reasonable explanation of the observed phenomenon
may be that Complex I from E. coli also has an additional 14th subunit,
which is not itself important for catalysis, but which increases enzyme
stability, as does Nqo15 in T. thermophilus [3]. If this additional subunit is
bound more loosely than in the T. thermophilus enzyme, it may be
washed out in the steps of enzyme puriﬁcation yielding a low
population in the puriﬁed enzyme. Loss of this subunit, which may
shield the cation binding site, would result in increased accessibility of
the site for the chelators and/or a decreased afﬁnity for Ca2+. In turn, the
removal of Ca2+ may disturb the interaction between the NuoF and
NuoE subunits and result in structural changes in the catalytic site.
Nqo15 in T. thermophiluswas characterized by its fold as a frataxin-like
protein [2]. The gene for Nqo15 is not located in the nqo operon
encoding 14 subunits of Complex I but in a locus separated from it by
~360 kb [3]. The operon nuo encoding the 13 subunits of Complex I in
E. coli also does not contain an additional gene, and there is no gene
homologous to the Nqo15 protein by primary amino acid sequence in
the whole E. coli genome. However, there is a gene for at least one
protein belonging to the frataxin family as judged by its fold, namely
CyaY (PDB 1EW4 and 1SOY [19,20]). The exact function of CyaY is not
clearly identiﬁed yet, but as a frataxin orthologue it is proposed to carry
iron and pass it on to other proteins [20]. Earlier CyaY was suggested to
be a component of the E. coli Complex I. However, this possibility was
excluded by deletion of cyaY and by locating CyaY in the cytoplasm by
means of live cell imaging [21]. The frataxin-like component of Complex
I may be a unique property of thermophilic bacteria. On the other hand,
it is probable that the sensitivity of puriﬁed Complex I to chelators
results froma loss of a protecting Ca2+binding site stability factorwhich
is not a protein or a polypeptide, but another component of the native
membrane. Speciﬁc lipids seem unlikely since the chelators affect not
only the ubiquinone reductase activity but also the artiﬁcial HAR and
FeCy reductase activities, which require the operation of only two
subunits, NuoE and NuoF, located far away from themembrane. Further
work is required to clarify the nature of the stability factor and it is in
progress now.
Protection of Complex I from chelators by K+ ions may be
explained by the fact that K+ is an essential component of bacterial
and eukaryotic cell cytoplasm, always present at high concentrations.
Therefore, we argue that all proteins operating in the cytoplasm are
adapted to that condition. Some of these proteins, including Complex I
whose soluble domain is in the bacterial cytoplasm, require a
physiological K+ concentration to maintain their correct conforma-
tion. Previously, we demonstrated a high-afﬁnity K+ binding site in
Complex I that affected its activity [10]. However, it seems probable
that the enzyme also contains multiple low-afﬁnity K+ binding sites
preserving its conformation.
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